MSD has announced interim results of a trial involving anti-PD-1 antibody KEYTRUDA (pembrolizumab) for the treatment of bladder cancer. …
Latest Video
New Stories
-
Bayer venture capital arm invests in 'off the shelf' CAR-T
July 17, 2019 - - Latest News -
Servier in new collaboration with Melbourne's BioCurate
July 17, 2019 - - Latest News -
How do we even know what patients are missing out on?
July 17, 2019 - - Latest News -
MA simply cannot say 'no' on supply chain reform
July 17, 2019 - - Latest News -
Gilead ups stake in biotech and expands cell manufacturing
July 17, 2019 - - Latest News -
Imugene acquires rights to new oncolytic virus technology
July 16, 2019 - - Latest News -
Focus on reality rather than the language
July 16, 2019 - - Latest News